Solas-Lung
Lead Participant:
SIERRA MEDICAL LTD
Abstract
_Solas-Lung_ reinforces a partnership between BeamLine and University College London (UCL) with the primary project aim to complete the 400 patient first in clinic trial required for developing our technology towards regulatory approval: advancing _Solas-Lung_ to TRL6/7\. UCL have supported IR detection of cancerous cells with \>10 years of ground-breaking research. They are the ideal clinical partner to progress _Solas-Lung_ to the next stage, and complement with world leading researchers, to produce a rounded team to ensure project success.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| SIERRA MEDICAL LTD | £665,083 | £ 465,560 |
Participant |
||
| PORTSMOUTH HOSPITALS NHS TRUST | £285,036 | £ 285,036 |
| BEAMLINE DIAGNOSTICS LIMITED | £665,083 | £ 465,560 |
| INNOVATE UK | ||
| PORTSMOUTH HOSPITALS UNIVERSITY NHS TRUST | ||
| UNIVERSITY COLLEGE LONDON |
People |
ORCID iD |
| Liberty Foreman (Project Manager) |